Literature DB >> 6285893

Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens.

G Murphy, J J Reynolds, U Bretz, M Baggiolini.   

Abstract

The separation and further purification of human polymorphonuclear-leucocyte collagenase and gelatinase, using modifications of the method of Cawston & Tyler [(1979) Biochem J. 183, 647-656], are described. The final preparations yielded collagenase of specific activity 260 units/mg and gelatinase of specific activity 13 000 units/mg. Gelatinase was purified to apparent homogeneity in a latent form, and analysis of the activation of 125I-labelled latent enzyme by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and gel-filtration techniques suggested that no peptide material was lost on conversion into the active form. The purified natural inhibitors alpha 2-macroglobulin, tissue inhibitor of metalloproteinases ('TIMP') and amniotic-fluid inhibitor of metalloproteinases all inhibited the two polymorphonuclear-leucocyte metalloproteinases, but the last two inhibitors were slow to act and complete inhibition was difficult to attain. Collagenase degraded soluble types I and III collagen equally efficiently, but soluble type II collagen less well. Gelatinase alone had little activity on these substrates, although it enhanced the action of collagenase. Gelatinase was capable of degrading soluble types IV and V collagen at 25 degrees C, whereas collagenase was only active at higher temperatures when the collagens were susceptible to trypsin activity. By using tissue preparations of insoluble collagens (type I, II or IV) the activity of leucocyte collagenase was low and gelatinase activity was negligible, as measured by the solubilization of hydroxyproline-containing material. The two enzymes together were two or three times more effective in the degradation of these insoluble collagens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285893      PMCID: PMC1158212          DOI: 10.1042/bj2030209

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Action of rheumatoid synovial collagenase on cartilage collagen. Different susceptibilities of cartilage and tendon collagen to collagenase attack.

Authors:  D E Woolley; K A Lindberg; R W Glanville; J M Evanson
Journal:  Eur J Biochem       Date:  1975-01-02

2.  Resistance to collagenase: a characteristic of collagen fibrils cross-linked by formaldehyde.

Authors:  E D Harris; M E Farrell
Journal:  Biochim Biophys Acta       Date:  1972-08-31

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

5.  Presence of a gelatin-specific proteinase and its latent form in human leucocytes.

Authors:  I Sopata; A M Dancewicz
Journal:  Biochim Biophys Acta       Date:  1974-12-29

6.  The interaction of alpha2-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases.

Authors:  Z Werb; M C Burleigh; A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

7.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  Cathepsin B1. A lysosomal enzyme that degrades native collagen.

Authors:  M C Burleigh; A J Barrett; G S Lazarus
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

9.  A specific collagenase from rabbit fibroblasts in monolayer culture.

Authors:  Z Werb; M C Burleigh
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

10.  Biochemical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes.

Authors:  U Bretz; M Baggiolini
Journal:  J Cell Biol       Date:  1974-10       Impact factor: 10.539

View more
  39 in total

1.  Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid.

Authors:  C M Overall; J Sodek; C A McCulloch; P Birek
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.

Authors:  Wenjie Wang; Serena Viappiani; Jolanta Sawicka; Richard Schulz
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury.

Authors:  C A Herbert; M J Arthur; C Robinson
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.

Authors:  M J Arthur; S L Friedman; F J Roll; D M Bissell
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Degradation of glomerular basement membrane by purified mammalian metalloproteinases.

Authors:  W H Baricos; G Murphy; Y W Zhou; H H Nguyen; S V Shah
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

6.  The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells.

Authors:  M Davies; G J Thomas; J Martin; D H Lovett
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

7.  Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.

Authors:  M C Vissers; P M George; I C Bathurst; S O Brennan; C C Winterbourn
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

8.  Human neutrophil gelatinase is a component of specific granules.

Authors:  M S Hibbs; D F Bainton
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Heterogeneity among human collagenases demonstrated by monoclonal antibody that selectively recognizes and inhibits human neutrophil collagenase.

Authors:  K A Hasty; M S Hibbs; A H Kang; C L Mainardi
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

10.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

Authors:  M Mohtai; R L Smith; D J Schurman; Y Tsuji; F M Torti; N I Hutchinson; W G Stetler-Stevenson; G I Goldberg
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.